Evidence map›Paper›PMID 38271445›Full record

SynthesisPloS one2024

Efficacy of cutting balloon angioplasty versus high-pressure balloon angioplasty for the treatment of arteriovenous fistula stenoses in patients undergoing hemodialysis: Systematic review and meta-analysis.

Shuyue Pang, Tianying Chang, Mingxin Chang, Xu Huang, Xiaodan Wang, Meijin Song, Zhongtian Wang, Shoulin Zhang

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shuyue PangCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun Jilin, China.ORCID 0009-0005-9251-7748
Tianying ChangEBM Office, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun Jilin, China.
Mingxin ChangNephrology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun Jilin, China.
Xu HuangNephrology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun Jilin, China.
Xiaodan WangCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun Jilin, China.
Meijin SongCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun Jilin, China.
Zhongtian WangCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun Jilin, China.
Shoulin ZhangNephrology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun Jilin, China.ORCID 0000-0003-2985-1661
Changchun University of Chinese Medicine · CNThe Affiliated Hospital to Changchun University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic review and meta-analysis aimed to assess and compare the therapeutic outcomes of cutting balloon angioplasty and high-pressure balloon angioplasty for arteriovenous fistula stenosis in hemodialysis patients. All studies indexed in PubMed, Embase, and Cochrane Library Web of Science were retrieved. The retrieval deadline was July 15, 2023. Risk of bias 2.0 was used to evaluate the quality of the included studies. Revman 5.4 software was used for data analysis. This review included three studies and 180 patients, with 90 patients in the cutting balloon angioplasty group and 90 patients in the high-pressure balloon angioplasty group. The results of the meta-analysis suggested that compared with high-pressure balloon angioplasty, cutting balloon angioplasty can improve primary lesion patency rates of internal arteriovenous fistulas at 6 months (relative risk, 1.45; 95% confidence interval, 1.08-1.96; P = 0.01). However, there were no significant differences between the technical success rate (relative risk, 0.99; 95% confidence interval, 0.93-1.05; P = 0.72) and clinical success rate (relative risk, 1.01; 95% confidence interval, 0.95-1.07; P = 0.73). Therefore, cutting balloon angioplasty is likely to increase primary lesion patency rates at 6 months. However, more high-quality, large-sample, multicenter, randomized controlled trials are needed for further validation due to the limited number of included studies.

Indexed as

Angioplasty, BalloonArteriovenous FistulaArteriovenous Shunt, SurgicalConstriction, PathologicGraft Occlusion, VascularHumansMulticenter Studies as TopicRenal DialysisTreatment OutcomeVascular Patency

Identifiers

PMID38271445
PMCPMC10810470
OpenAlexW4391217496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.